Tu1724 EFFECT OF ETRASIMOD ON IMMUNE CELL SUBSETS IN COLONIC TISSUE OF PATIENTS WITH ULCERATIVE COLITIS: IMMUNOPHENOTYPING ANALYSIS OF COLON BIOPSY SAMPLES FROM THE PHASE 3 ELEVATE UC 52 AND ELEVATE UC 12 TRIALS

Britta Siegmund; H. Kiyomi Komori; Maria T. Abreu; Séverine Vermeire; Iris Dotan; Martina Goetsch; Catherine Crosby; Rathi D. Ryan; John Woolcott; Silvio Danese

doi:10.1016/S0016-5085(23)03540-0

Back

Tu1724 EFFECT OF ETRASIMOD ON IMMUNE CELL SUBSETS IN COLONIC TISSUE OF PATIENTS WITH ULCERATIVE COLITIS: IMMUNOPHENOTYPING ANALYSIS OF COLON BIOPSY SAMPLES FROM THE PHASE 3 ELEVATE UC 52 AND ELEVATE UC 12 TRIALS

Journal article

Peer reviewed

Tu1724 EFFECT OF ETRASIMOD ON IMMUNE CELL SUBSETS IN COLONIC TISSUE OF PATIENTS WITH ULCERATIVE COLITIS: IMMUNOPHENOTYPING ANALYSIS OF COLON BIOPSY SAMPLES FROM THE PHASE 3 ELEVATE UC 52 AND ELEVATE UC 12 TRIALS

Britta Siegmund, H. Kiyomi Komori, Maria T. Abreu, Séverine Vermeire, Iris Dotan, Martina Goetsch, Catherine Crosby, Rathi D. Ryan, John Woolcott and Silvio Danese

Gastroenterology (New York, N.Y. 1943), Vol.164(6), pp.S-1095-S-1095

2023-05

DOI: https://doi.org/10.1016/S0016-5085(23)03540-0

Appears in Miller School of Medicine - Latest Publications

Metrics

1 Record Views

Details

Title: Tu1724 EFFECT OF ETRASIMOD ON IMMUNE CELL SUBSETS IN COLONIC TISSUE OF PATIENTS WITH ULCERATIVE COLITIS: IMMUNOPHENOTYPING ANALYSIS OF COLON BIOPSY SAMPLES FROM THE PHASE 3 ELEVATE UC 52 AND ELEVATE UC 12 TRIALS
Creators: Britta Siegmund
H. Kiyomi Komori
Maria T. Abreu
Séverine Vermeire
Iris Dotan
Martina Goetsch
Catherine Crosby
Rathi D. Ryan
John Woolcott
Silvio Danese
Publication Details: Gastroenterology (New York, N.Y. 1943), Vol.164(6), pp.S-1095-S-1095
Publisher: Elsevier Inc
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Gastroenterology
Language: English
Resource Type: Journal article
Record Identifier: 991031821351102976